SARS-CoV-2 epidemic in Brazil: how variants displacement have driven distinct epidemic waves
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor | Lab. Fisiopatologia | pt_BR |
dc.contributor | (LCC) Lab. Ciclo Celular | pt_BR |
dc.contributor | Programa de Pós-Graduação em Ciências – Toxinologia (PPGTox) | pt_BR |
dc.contributor.author | Junior Alcantara, Luiz Carlos | pt_BR |
dc.contributor.author | Nogueira, Elisson | pt_BR |
dc.contributor.author | Shuab, Gabriel | pt_BR |
dc.contributor.author | Sampaio, Sandra Coccuzzo | pt_BR |
dc.contributor.author | Elias, Maria Carolina | pt_BR |
dc.date.accessioned | 2022-04-25T16:14:34Z | - |
dc.date.available | 2022-04-25T16:14:34Z | - |
dc.date.issued | 2022 | pt_BR |
dc.identifier.citation | Junior Alcantara LC, Nogueira E, Shuab G, Tosta S, Fristch H, Pimentel V, et al. SARS-CoV-2 epidemic in Brazil: how variants displacement have driven distinct epidemic waves. Virus Res. 2022 Jul; 315:198785. doi:10.1016/j.virusres.2022.198785. | pt_BR |
dc.identifier.uri | https://repositorio.butantan.gov.br/handle/butantan/4308 | - |
dc.description.abstract | Brazil ranks as third in terms of total number of reported SARS-CoV-2 cases globally. The COVID-19 epidemic in Brazil was characterised by the co-circulation of multiple variants as a consequence of multiple independent introduction events occurring through time. Here, we describe the SARS-CoV-2 variants that are currently circulating and co-circulating in the country, with the aim to highlight which variants have driven the different epidemic waves. For this purpose, we retrieved metadata information of Coronavirus sequences collected in Brazil and available at the GISAID database. SARS-CoV-2 lineages have been identified along with eleven variants, labelled as VOCs (Alpha, Gamma, Beta, Delta and Omicron) VOIs (Lambda and Mu) VUMs (B.1.1.318) and FMVs (Zeta, Eta and B.1.1.519). Here we show that, in the Brazilian context, after 24 months of sustained transmission and evolution of SARS-CoV-2, local variants (among them the B.1.1.28 and B.1.1.33) were displaced by recently introduced VOCs firstly with the Gamma, followed by Delta and more recently Omicron. The rapid spread of some of those VOCs (such as Gamma and Omicron) was also mirror by a large increase in the number of cases and deaths in the country. This in turn reinforces that, due to the emergence of variants that appear to induce a substantial evasion against neutralizing antibody response, it is important to strengthen genomic effort within the country and how vaccination still remains a critical process to protect the vulnerable population, still at risk of infection and death. | pt_BR |
dc.description.sponsorship | (NIH) National Institutes of Health | pt_BR |
dc.description.sponsorship | (UWARN) United World Antiviral Research Network | pt_BR |
dc.description.sponsorship | (FIOCRUZ) Fundação Oswaldo Cruz | pt_BR |
dc.description.sponsorship | Ministério da Saúde do Brasil | pt_BR |
dc.description.sponsorship | (FAPERJ) Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro | pt_BR |
dc.format.extent | 198785 | pt_BR |
dc.language.iso | English | pt_BR |
dc.relation.ispartof | Virus Research | pt_BR |
dc.rights | Open access | pt_BR |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | pt_BR |
dc.title | SARS-CoV-2 epidemic in Brazil: how variants displacement have driven distinct epidemic waves | pt_BR |
dc.type | Article | pt_BR |
dc.rights.license | CC BY-NC-ND | pt_BR |
dc.identifier.doi | 10.1016/j.virusres.2022.198785 | pt_BR |
dc.contributor.external | (IOC) Instituto Oswaldo Cruz | pt_BR |
dc.contributor.external | (UFMG) Universidade Federal de Minas Gerais | pt_BR |
dc.contributor.external | (NOVA) Universidade Nova de Lisboa | pt_BR |
dc.contributor.external | (UNESP) Universidade Estadual Paulista Júlio de Mesquita Filho | pt_BR |
dc.contributor.external | University of Campus Bio-Medico di Roma | pt_BR |
dc.contributor.external | University of Central Florida | pt_BR |
dc.contributor.external | University of Oxford | pt_BR |
dc.contributor.external | (ULISBOA) Universidade de Lisboa | pt_BR |
dc.contributor.external | (OPAS) Organização Pan-Americana da Saúde | pt_BR |
dc.contributor.external | (UKZN) University of KwaZulu-Natal | pt_BR |
dc.contributor.external | (IHMT) Instituto de Higiene e Medicina Tropical | pt_BR |
dc.contributor.external | (USP) Universidade de São Paulo | pt_BR |
dc.identifier.citationvolume | 315 | pt_BR |
dc.subject.keyword | SARS-CoV-2 | pt_BR |
dc.subject.keyword | variants | pt_BR |
dc.subject.keyword | Brazil | pt_BR |
dc.subject.keyword | surveillance | pt_BR |
dc.relation.ispartofabbreviated | Virus Res | pt_BR |
dc.identifier.citationabnt | v. 315, 198785, jul. 2022 | pt_BR |
dc.identifier.citationvancouver | 2022 Jul; 315:198785 | pt_BR |
dc.contributor.butantan | Sampaio, Sandra Coccuzzo|:Pesquisador|:Docente Permanente PPGTox|:Programa de Pós-Graduação em Ciências – Toxinologia (PPGTox)|:Lab. Fisiopatologia | pt_BR |
dc.contributor.butantan | Elias, Maria Carolina|:Pesquisador|:LCC - Laboratório de Ciclo Celular | pt_BR |
dc.sponsorship.butantan | (NIH) National Institutes of Health¦¦U01 AI151698 | pt_BR |
dc.sponsorship.butantan | (UWARN) United World Antiviral Research Network¦¦ | pt_BR |
dc.sponsorship.butantan | (ICGEB) International Centre for Genetic Engineering and Biotechnology¦¦CRP/BRA20-03 | pt_BR |
dc.sponsorship.butantan | (ICGEB) International Centre for Genetic Engineering and Biotechnology¦¦CRP/20/03 | pt_BR |
dc.sponsorship.butantan | (FIOCRUZ) Fundação Oswaldo Cruz¦¦VPGDI-027-FIO-20-2-2-30 | pt_BR |
dc.sponsorship.butantan | Ministério da Saúde do Brasil¦¦SCON2021-00180 | pt_BR |
dc.sponsorship.butantan | (FAPERJ) Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro¦¦ | pt_BR |
dc.identifier.bvscc | BR78.1 | pt_BR |
dc.identifier.bvsdb | IBProd | pt_BR |
dc.description.dbindexed | Yes | pt_BR |
item.fulltext | Com Texto completo | - |
item.openairetype | Article | - |
item.languageiso639-1 | English | - |
item.grantfulltext | open | - |
crisitem.author.dept | #PLACEHOLDER_PARENT_METADATA_VALUE# | - |
crisitem.author.dept | #PLACEHOLDER_PARENT_METADATA_VALUE# | - |
crisitem.author.dept | #PLACEHOLDER_PARENT_METADATA_VALUE# | - |
crisitem.author.dept | #PLACEHOLDER_PARENT_METADATA_VALUE# | - |
crisitem.author.dept | #PLACEHOLDER_PARENT_METADATA_VALUE# | - |
crisitem.author.orcid | #PLACEHOLDER_PARENT_METADATA_VALUE# | - |
crisitem.author.orcid | #PLACEHOLDER_PARENT_METADATA_VALUE# | - |
crisitem.author.orcid | #PLACEHOLDER_PARENT_METADATA_VALUE# | - |
crisitem.author.orcid | 0000-0001-6257-3531 | - |
crisitem.author.orcid | #PLACEHOLDER_PARENT_METADATA_VALUE# | - |
crisitem.author.parentorg | #PLACEHOLDER_PARENT_METADATA_VALUE# | - |
crisitem.author.parentorg | #PLACEHOLDER_PARENT_METADATA_VALUE# | - |
crisitem.author.parentorg | #PLACEHOLDER_PARENT_METADATA_VALUE# | - |
crisitem.journal.journalissn | #PLACEHOLDER_PARENT_METADATA_VALUE# | - |
crisitem.journal.journaleissn | #PLACEHOLDER_PARENT_METADATA_VALUE# | - |
Appears in Collections: | Artigos |
Files in This Item:
SARS-CoV-2 epidemic in Brazil how the displacement of variants has.pdf
Size: 571.67 kB
Format: Adobe PDF
View/Open
Size: 571.67 kB
Format: Adobe PDF
View/Open
This item is licensed under a Creative Commons License